• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»New subtype of prostate cancer identified by researchers

New subtype of prostate cancer identified by researchers

Loknath Das 26 Jun 2018 Health Comments Off on New subtype of prostate cancer identified by researchers 599 Views

It is imperative to get your prostate cancer screening done regularly.

Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced diseases.

The subtype is characterised by loss of the gene CDK12. It was found to be a more common in metastatic prostate cancer compared to early stage tumours that had not spread, said the study published in the journal Cell.

“Because prostate cancer is so common, 7% is a significant number,” said senior study author Arul Chinnaiyan from the University of Michigan in the US.

Tumours in which CDK12 was inactivated were responsive to immune checkpoint inhibitors, a type of immunotherapy treatment that has overall had limited success in prostate cancer, the study said.

“The fact that immune checkpoint inhibitors may be effective against this sub-type of prostate cancer makes it even more significant. This is an exciting prospect for patients who have CDK12 alterations and may benefit from immunotherapy,” Chinnaiyan added.

The researchers said they will lead a multisite clinical trial to assess checkpoint inhibitors as a treatment for metastatic prostate cancer with CDK12 loss.

In this study, the researchers looked at DNA and RNA sequencing data from 360 tumour samples from patients with metastatic castration-resistant prostate cancer.

This is an aggressive, advanced form of the disease in which the cancer has spread throughout the body and no longer responds to traditional hormone-based treatments.

The researchers found loss of CDK12 in only about 1% of early prostate cancer samples. That jumped to 7% for metastatic cancer, which indicates a more-aggressive form of the disease.

By following the mechanism of how CDK12 loss impacts the cell, the researchers found a process in which cells create neoantigens that are foreign to the immune system. This boosts immune-fighting T-cells, which may explain why these patients benefit from immune checkpoint blockade.

 

 

[“source=hindustantimes”]

by cancer identified New of prostate researchers subtype 2018-06-26
Tags by cancer identified New of prostate researchers subtype
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Loknath Das
Previous Article :

When the porch decor comes out of winter storage, the magic begins

Next Article :

Online information on vaccines and autism may be unreliable

Related Articles

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

admin 16 Nov 2026
The Best Healthy Living Blogs of 2020

The Best Healthy Living Blogs of 2020

admin 05 Nov 2026
Can Men Hold Off on Treating Recurring Prostate Cancer?

Can Men Hold Off on Treating Recurring Prostate Cancer?

admin 04 Nov 2026

Latest Post

Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025
Home Deco

Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025

admin 16 Nov 2026
Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection
Health

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

admin 16 Nov 2026
The Best Healthy Living Blogs of 2020
Health

The Best Healthy Living Blogs of 2020

admin 05 Nov 2026
Can Men Hold Off on Treating Recurring Prostate Cancer?
Health

Can Men Hold Off on Treating Recurring Prostate Cancer?

admin 04 Nov 2026
Migraine or Just a Bad Headache? How to Tell the Difference
Health

Migraine or Just a Bad Headache? How to Tell the Difference

admin 31 Oct 2026
Menopause and Your Heart: The Connection Every Woman Should Know
Health

Menopause and Your Heart: The Connection Every Woman Should Know

admin 31 Oct 2026
Share Your Education Insights with Remainder Calculator
Education

Share Your Education Insights with Remainder Calculator

admin 27 Oct 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme